| Literature DB >> 25283357 |
Beth A Lubeck1, Philip E Lapinski1, Timothy J Bauler1, Jennifer A Oliver1, Elizabeth D Hughes2, Thomas L Saunders3, Philip D King4.
Abstract
Capillary malformation-arteriovenous malformation (CM-AVM) is an autosomal dominant blood vascular (BV) disorder characterized by CM and fast flow BV lesions. Inactivating mutations of the RASA1 gene are the cause of CM-AVM in most cases. RASA1 is a GTPase-activating protein that acts as a negative regulator of the Ras small GTP-binding protein. In addition, RASA1 performs Ras-independent functions in intracellular signal transduction. Whether CM-AVM results from loss of an ability of RASA1 to regulate Ras or loss of a Ras-independent function of RASA1 is unknown. To address this, we generated Rasa1 knockin mice with an R780Q point mutation that abrogates RASA1 catalytic activity specifically. Homozygous Rasa1(R780Q/R780Q) mice showed the same severe BV abnormalities as Rasa1-null mice and died midgestation. This finding indicates that BV abnormalities in CM-AVM develop as a result of loss of an ability of RASA1 to control Ras activation and not loss of a Ras-independent function of this molecule. More important, findings indicate that inhibition of Ras signaling is likely to represent an effective means of therapy for this disease.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25283357 PMCID: PMC4258499 DOI: 10.1016/j.ajpath.2014.08.018
Source DB: PubMed Journal: Am J Pathol ISSN: 0002-9440 Impact factor: 4.307